QUOTE AND NEWS
StreetInsider.com  Nov 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Wells+Fargo+Upgrades+Symmetry+Medical+%28SMA%29+to+Market+Perform%3B+Cycle+Has+Bottomed/5125257.html for the full story.
PR Newswire  Nov 16  Comment 
WARSAW, Ind., Nov. 16 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief
Stock Blog Hub  Nov 9  Comment 
Symmetry Medical, Inc. (SMA) reported third-quarter earnings per share of 15 cents that came in a penny shy of the Zacks Consensus Estimate. However, earnings came ahead of last year’s figure of 7 cents. Sales Total sales in the reported...
StreetInsider.com  Nov 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Symmetry+Medical+%28SMA%29+Misses+Q3+EPS+by+1c%3B+Guides+Lower/5078031.html for the full story.
PR Newswire  Nov 5  Comment 
WARSAW, Ind., Nov. 5 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced third quarter 2009 financial results for the
Stock Blog Hub  Oct 29  Comment 
Symmetry Medical Inc. (SMA) has lowered its revenues and earnings per share guidance for the full fiscal 2009. Revenues are now expected in the range of $355 to $365 million, lower than its previous guidance of $385 to $405 million. Earnings per...
AlphaNinja  Oct 26  Comment 
Aging baby-boomers, until now flush with cash, are expecting to not only live longer, but expect to live longer relatively pain free. Thus goes the logic behind owning shares like those of Symmetry Medical Inc (SMA), a maker of hip and knee...
StreetInsider.com  Oct 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Symmetry+Medical+%28SMA%29+Lowers+FY09+Sales%2C+EPS+Outlook/5043201.html for the full story.
PR Newswire  Oct 26  Comment 
WARSAW, Ind., Oct. 26 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today updated full year 2009 financial
PR Newswire  Oct 21  Comment 
WARSAW, Ind., Oct. 21 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that it will release third quarter 2009
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
 
TOP CONTRIBUTORS
SMA AT A GLANCE
 
 
 
 
 
 
 
 

Symmetry Medical, Inc., headquartered in Warsaw, Indiana, went public in December 2004 but was established in 1976 as an instruments supplier to orthopedic device manufacturers. In 1996, Symmetry acquired a manufacturer of cases to extend its product offerings. In 1998 and 1999, the company expanded its overseas presence by acquiring a UK instruments manufacturer and a cases manufacturer in France. In 2003, the company acquired Mettis (UK) Limited, a leading manufacturer of forged, cast and machined implants. The company is now the world's largest independent provider of implants and related instruments and cases to orthopedic device manufacturers. The company also designs, develops, and produces these products for companies in other segments of the medical device market, including dental, osteobiologic, and endoscopy sectors, and provides limited specialized products and services to non-healthcare markets, such as the aerospace market. The company provides its customers with a broad range of products, comprehensive services, and production capabilities through its Total Solutions approach. Symmetry Medical derives its revenue principally from four segments: implants, instruments, cases, and other products and services. The company provides implants for use in specific implant systems, mainly in knee and hip implants. Orthopedic implants are used in reconstructive surgeries to replace or repair hips, knees, and other joints, primarily shoulders, ankles, and elbows. Symmetry Medical also manufactures implant products for trauma, spine, and other implant systems. The company makes precision surgical instruments used in hip, knee, and shoulder reconstruction procedures, and in spinal, trauma, and other implant procedures. It also provides implant-specific and procedure-specific instruments. The company also produces plastic, metal, and hybrid cases to store, transport, and arrange surgical instruments and related implant systems for orthopedic device manufacturers. Dental cases are used in dental implant and general dental procedures. Other cases are used for arthroscopy, osteobiologic, endoscopy, cardiovascular, ophthalmology, and diagnostic imaging, as well as ear, nose, and throat procedures. In Q406, net revenues were $58.5 million, with implants, instruments, cases, and other products and services contributing 40%, 22%, 25%, and 13%, respectively. The company markets its Total Solutions approach through its experienced sales force that operates in the United States, Europe, and Japan. Geographically, in Q406, the United States, United Kingdom, and others contributed 58%, 22%, and 20% respectively.




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki